Efforts to develop the world’s first vaccine to prevent cervical cancer took a key step forward Monday with test results suggesting that it can provide long-lasting protection. Four years after getting the vaccine, 94 percent of women were protected from infection with the virus that causes most cervical cancers and none had developed worrisome precancerous conditions, a study showed.
